

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02506197 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.95459966 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.62360782 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.62360782 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.59728624 |
| 6 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.50501860 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35240554 |
| 8 | leukocyte aggregation (GO:0070486) | 4.26735977 |
| 9 | respiratory burst (GO:0045730) | 3.98218916 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 3.92997115 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91239774 |
| 12 | sequestering of actin monomers (GO:0042989) | 3.79611855 |
| 13 | neutrophil activation (GO:0042119) | 3.79109609 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77916545 |
| 15 | detection of other organism (GO:0098543) | 3.74470876 |
| 16 | response to peptidoglycan (GO:0032494) | 3.73041935 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64867527 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.64867527 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64867527 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64867527 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64867527 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.64867527 |
| 23 | granulocyte activation (GO:0036230) | 3.63059582 |
| 24 | detection of bacterium (GO:0016045) | 3.46043230 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 3.45347500 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42659594 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 3.41998735 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.35414648 |
| 29 | * actin nucleation (GO:0045010) | 3.34718539 |
| 30 | positive regulation of lamellipodium assembly (GO:0010592) | 3.32363519 |
| 31 | type I interferon signaling pathway (GO:0060337) | 3.30321652 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.30321652 |
| 33 | response to type I interferon (GO:0034340) | 3.29029723 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.27780640 |
| 35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.25426665 |
| 36 | microglial cell activation (GO:0001774) | 3.24158580 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22692483 |
| 38 | B cell mediated immunity (GO:0019724) | 3.21798140 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19255953 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.18121450 |
| 41 | T cell migration (GO:0072678) | 3.17100102 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.14198906 |
| 43 | cellular response to zinc ion (GO:0071294) | 3.12427948 |
| 44 | myeloid dendritic cell activation (GO:0001773) | 3.10660735 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 3.05774857 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05511656 |
| 47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04393098 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02569534 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.00427430 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 3.00427430 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 2.99224070 |
| 52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98580892 |
| 53 | myeloid dendritic cell differentiation (GO:0043011) | 2.97933757 |
| 54 | defense response to protozoan (GO:0042832) | 2.97250329 |
| 55 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.96662687 |
| 56 | cellular response to interferon-beta (GO:0035458) | 2.96660913 |
| 57 | cellular extravasation (GO:0045123) | 2.96352226 |
| 58 | negative thymic T cell selection (GO:0045060) | 2.95310489 |
| 59 | regulation of antigen processing and presentation (GO:0002577) | 2.94859112 |
| 60 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94292247 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94292247 |
| 62 | response to protozoan (GO:0001562) | 2.93620475 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 2.93477164 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 2.93194498 |
| 65 | macrophage activation (GO:0042116) | 2.92172862 |
| 66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91825965 |
| 67 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91723313 |
| 68 | response to muramyl dipeptide (GO:0032495) | 2.91469986 |
| 69 | positive regulation of macrophage differentiation (GO:0045651) | 2.91176823 |
| 70 | leukocyte cell-cell adhesion (GO:0007159) | 2.90745821 |
| 71 | negative regulation of phagocytosis (GO:0050765) | 2.90745401 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90142310 |
| 73 | barbed-end actin filament capping (GO:0051016) | 2.89854102 |
| 74 | positive regulation of lamellipodium organization (GO:1902745) | 2.88618563 |
| 75 | response to interferon-beta (GO:0035456) | 2.88540077 |
| 76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.88336870 |
| 77 | negative regulation of cell killing (GO:0031342) | 2.88128914 |
| 78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88128914 |
| 79 | negative T cell selection (GO:0043383) | 2.86082087 |
| 80 | natural killer cell mediated immunity (GO:0002228) | 2.85594118 |
| 81 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.85594118 |
| 82 | detection of biotic stimulus (GO:0009595) | 2.85336577 |
| 83 | dendritic cell migration (GO:0036336) | 2.85161561 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.84049363 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83199868 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82608368 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.82181121 |
| 88 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.81862271 |
| 89 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81637275 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81511532 |
| 91 | cellular response to interleukin-15 (GO:0071350) | 2.80675631 |
| 92 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.78917569 |
| 93 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.78804606 |
| 94 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.78600319 |
| 95 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.78504829 |
| 96 | positive regulation of mast cell activation (GO:0033005) | 2.78469869 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 2.77184452 |
| 98 | hepatocyte apoptotic process (GO:0097284) | 2.76563301 |
| 99 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76094852 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 2.75767544 |
| 101 | lymphocyte chemotaxis (GO:0048247) | 2.75287661 |
| 102 | regulation of leukocyte degranulation (GO:0043300) | 2.74799987 |
| 103 | dendritic cell chemotaxis (GO:0002407) | 2.74654288 |
| 104 | mast cell activation (GO:0045576) | 2.73236962 |
| 105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.72599358 |
| 106 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.71703622 |
| 107 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.71577175 |
| 108 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70680394 |
| 109 | leukocyte mediated cytotoxicity (GO:0001909) | 2.70404920 |
| 110 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69773656 |
| 111 | regulation of mast cell activation (GO:0033003) | 2.69521663 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.68613004 |
| 113 | negative regulation of interleukin-17 production (GO:0032700) | 2.68464994 |
| 114 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.67511980 |
| 115 | response to host (GO:0075136) | 2.67364452 |
| 116 | response to host defenses (GO:0052200) | 2.67364452 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.67364452 |
| 118 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65700179 |
| 119 | response to host immune response (GO:0052572) | 2.65700179 |
| 120 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.64832127 |
| 121 | regulation of mast cell degranulation (GO:0043304) | 2.64751142 |
| 122 | positive regulation of isotype switching (GO:0045830) | 2.64735868 |
| 123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.63411228 |
| 124 | leukocyte degranulation (GO:0043299) | 2.63274255 |
| 125 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62594587 |
| 126 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.62480081 |
| 127 | interferon-gamma production (GO:0032609) | 2.61601488 |
| 128 | dendritic cell differentiation (GO:0097028) | 2.61317521 |
| 129 | signal peptide processing (GO:0006465) | 2.60443077 |
| 130 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.59179833 |
| 131 | myeloid leukocyte activation (GO:0002274) | 2.59170708 |
| 132 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.58073221 |
| 133 | negative regulation of interleukin-12 production (GO:0032695) | 2.56333553 |
| 134 | response to interleukin-15 (GO:0070672) | 2.56300611 |
| 135 | regulation of RIG-I signaling pathway (GO:0039535) | 2.53282807 |
| 136 | natural killer cell activation (GO:0030101) | 2.52387262 |
| 137 | positive regulation of interferon-beta production (GO:0032728) | 2.50589646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.31036888 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.97179916 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.08084605 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.88838695 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57136643 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45815237 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.23337473 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.15577435 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.11812858 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.02573618 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01742612 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01474806 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91794681 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.75784498 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74153028 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.64469476 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.63420978 |
| 18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54623799 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.52353913 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.47054710 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.28592595 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26526086 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.24955624 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22507478 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19824699 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14382319 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.11221195 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10245409 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.08229663 |
| 30 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00314643 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.99581350 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97124858 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95088268 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92411999 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91324807 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88013391 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86444739 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85464920 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.83809505 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.82027123 |
| 41 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77511025 |
| 42 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75982542 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73492833 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70112761 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59525196 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54781883 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51877905 |
| 48 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.50788190 |
| 49 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.50199824 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47710690 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46588163 |
| 52 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45131712 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43192150 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42978717 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37940058 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36219789 |
| 57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36157285 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35125220 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34270684 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31994382 |
| 61 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30166312 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29029356 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28709064 |
| 64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24199918 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23639512 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22314048 |
| 67 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.21248103 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20834721 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20700966 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18830376 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17354776 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.16853595 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14986161 |
| 74 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13178650 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12023147 |
| 76 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09773629 |
| 77 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09355571 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09131026 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08572747 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06925868 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05918479 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05868251 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05263317 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99497035 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98823735 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97389478 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96720196 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.96499737 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94438933 |
| 90 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.91832480 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91578462 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91164355 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89668036 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88358683 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87056565 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86291554 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84510597 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84212874 |
| 99 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83657925 |
| 100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.82687971 |
| 101 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.80633452 |
| 102 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.80281019 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80017023 |
| 104 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79477115 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79301059 |
| 106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79301059 |
| 107 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.77944406 |
| 108 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77408124 |
| 109 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.77128603 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76902844 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.76871625 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76782653 |
| 113 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.76614599 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71520625 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71270960 |
| 116 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64796493 |
| 117 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64185129 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63887472 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.61622221 |
| 120 | GATA3_26560356_Chip-Seq_TH1_Human | 0.61340598 |
| 121 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61075085 |
| 122 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.59688990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.45136436 |
| 2 | MP0003436_decreased_susceptibility_to | 3.60919522 |
| 3 | MP0009785_altered_susceptibility_to | 3.51454242 |
| 4 | MP0000685_abnormal_immune_system | 3.16823700 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.14673520 |
| 6 | MP0005671_abnormal_response_to | 3.12501795 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.08216733 |
| 8 | MP0001790_abnormal_immune_system | 2.83660719 |
| 9 | MP0005387_immune_system_phenotype | 2.83660719 |
| 10 | MP0002419_abnormal_innate_immunity | 2.81945389 |
| 11 | MP0005025_abnormal_response_to | 2.80457686 |
| 12 | MP0003303_peritoneal_inflammation | 2.78507302 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.76487681 |
| 14 | MP0001800_abnormal_humoral_immune | 2.73218602 |
| 15 | MP0002723_abnormal_immune_serum | 2.58642187 |
| 16 | MP0003724_increased_susceptibility_to | 2.56614307 |
| 17 | MP0001819_abnormal_immune_cell | 2.55251586 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.54752516 |
| 19 | MP0006082_CNS_inflammation | 2.40444287 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.20250223 |
| 21 | MP0002405_respiratory_system_inflammati | 2.16805933 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.12948312 |
| 23 | MP0002398_abnormal_bone_marrow | 2.10066844 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.06886753 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.02031245 |
| 26 | MP0001853_heart_inflammation | 2.01259046 |
| 27 | MP0000716_abnormal_immune_system | 1.98756698 |
| 28 | MP0002006_tumorigenesis | 1.97096125 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.96315100 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.87704552 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.87272516 |
| 32 | MP0004947_skin_inflammation | 1.85938467 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.82274658 |
| 34 | MP0004510_myositis | 1.71549015 |
| 35 | MP0002429_abnormal_blood_cell | 1.67521571 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.67474090 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.67443644 |
| 38 | MP0000858_altered_metastatic_potential | 1.64630118 |
| 39 | MP0002722_abnormal_immune_system | 1.63300342 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.61684497 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.59218813 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.59218813 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.59200105 |
| 44 | MP0003448_altered_tumor_morphology | 1.54907652 |
| 45 | MP0005310_abnormal_salivary_gland | 1.50915193 |
| 46 | MP0001873_stomach_inflammation | 1.46918673 |
| 47 | MP0002933_joint_inflammation | 1.46661110 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.43548559 |
| 49 | MP0006054_spinal_hemorrhage | 1.43427413 |
| 50 | MP0008469_abnormal_protein_level | 1.43162431 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.40436119 |
| 52 | MP0000343_altered_response_to | 1.36632194 |
| 53 | MP0000490_abnormal_crypts_of | 1.35951878 |
| 54 | MP0004883_abnormal_blood_vessel | 1.33588107 |
| 55 | MP0009764_decreased_sensitivity_to | 1.33547356 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.31665205 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.27629015 |
| 58 | MP0009278_abnormal_bone_marrow | 1.25349233 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.25245420 |
| 60 | MP0003866_abnormal_defecation | 1.22738567 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.22343195 |
| 62 | MP0008004_abnormal_stomach_pH | 1.21351885 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.21350307 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.15816823 |
| 65 | MP0008260_abnormal_autophagy | 1.12128778 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.11991936 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.11186225 |
| 68 | MP0003186_abnormal_redox_activity | 1.03195831 |
| 69 | MP0005451_abnormal_body_composition | 1.02528188 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.01326334 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.99501056 |
| 72 | MP0001542_abnormal_bone_strength | 0.96676244 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.95134514 |
| 74 | MP0001348_abnormal_lacrimal_gland | 0.93989250 |
| 75 | MP0005390_skeleton_phenotype | 0.93785448 |
| 76 | MP0001851_eye_inflammation | 0.91768529 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.91407872 |
| 78 | MP0003075_altered_response_to | 0.89862246 |
| 79 | MP0005166_decreased_susceptibility_to | 0.89487813 |
| 80 | MP0003693_abnormal_embryo_hatching | 0.86162147 |
| 81 | MP0003045_fibrosis | 0.84879427 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.84048740 |
| 83 | MP0002132_abnormal_respiratory_system | 0.83011960 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.81090956 |
| 85 | MP0010307_abnormal_tumor_latency | 0.81051280 |
| 86 | MP0005023_abnormal_wound_healing | 0.79258170 |
| 87 | MP0003795_abnormal_bone_structure | 0.78635839 |
| 88 | MP0003828_pulmonary_edema | 0.75753600 |
| 89 | MP0000249_abnormal_blood_vessel | 0.73223255 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.72379982 |
| 91 | MP0009763_increased_sensitivity_to | 0.71383402 |
| 92 | MP0009840_abnormal_foam_cell | 0.71304810 |
| 93 | MP0005164_abnormal_response_to | 0.70795894 |
| 94 | MP0002163_abnormal_gland_morphology | 0.70504186 |
| 95 | MP0005165_increased_susceptibility_to | 0.70238830 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.69388088 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.68873145 |
| 98 | MP0003091_abnormal_cell_migration | 0.67129488 |
| 99 | MP0001663_abnormal_digestive_system | 0.66112373 |
| 100 | MP0003690_abnormal_glial_cell | 0.66011141 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.65775176 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.64948691 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.64153738 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.62122787 |
| 105 | MP0003279_aneurysm | 0.60763586 |
| 106 | MP0001958_emphysema | 0.60171765 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.59929064 |
| 108 | MP0002139_abnormal_hepatobiliary_system | 0.59675384 |
| 109 | MP0000604_amyloidosis | 0.59347164 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.59173508 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.58331809 |
| 112 | MP0008007_abnormal_cellular_replicative | 0.57905325 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.56943724 |
| 114 | MP0001243_abnormal_dermal_layer | 0.56810084 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.56404317 |
| 116 | MP0008874_decreased_physiological_sensi | 0.56219733 |
| 117 | MP0000920_abnormal_myelination | 0.56185325 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.55332950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.24376326 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.18299172 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.39864208 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.89789069 |
| 5 | Myositis (HP:0100614) | 4.44348856 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.29958501 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.24592035 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.10403873 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.03996654 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.86134580 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.69147793 |
| 12 | Orchitis (HP:0100796) | 3.68863800 |
| 13 | Recurrent skin infections (HP:0001581) | 3.62736158 |
| 14 | Recurrent viral infections (HP:0004429) | 3.57196772 |
| 15 | Obstructive lung disease (HP:0006536) | 3.53656446 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53656446 |
| 17 | Cellulitis (HP:0100658) | 3.50994112 |
| 18 | Optic neuritis (HP:0100653) | 3.43104943 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.43104943 |
| 20 | Chronic otitis media (HP:0000389) | 3.34588054 |
| 21 | Petechiae (HP:0000967) | 3.31593964 |
| 22 | Vasculitis (HP:0002633) | 3.24483862 |
| 23 | Meningitis (HP:0001287) | 3.17402295 |
| 24 | Gingivitis (HP:0000230) | 3.13187654 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.12122979 |
| 26 | IgM deficiency (HP:0002850) | 3.06518786 |
| 27 | Recurrent bronchitis (HP:0002837) | 3.06327855 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.03066608 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.03066608 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.96754837 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.95942572 |
| 32 | Gingival bleeding (HP:0000225) | 2.95715491 |
| 33 | Pustule (HP:0200039) | 2.94423412 |
| 34 | Increased IgM level (HP:0003496) | 2.94374660 |
| 35 | Stomatitis (HP:0010280) | 2.92514651 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91061190 |
| 37 | Thrombocytosis (HP:0001894) | 2.90535056 |
| 38 | Abnormality of T cells (HP:0002843) | 2.82385471 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.76324350 |
| 40 | T lymphocytopenia (HP:0005403) | 2.74651441 |
| 41 | Leukocytosis (HP:0001974) | 2.73447001 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.69654612 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 2.68997877 |
| 44 | Loss of speech (HP:0002371) | 2.67340901 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.65841668 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.65051592 |
| 47 | Osteomyelitis (HP:0002754) | 2.61338746 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.60616026 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.60607891 |
| 50 | Recurrent pneumonia (HP:0006532) | 2.59129541 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.55834333 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53448686 |
| 53 | Severe combined immunodeficiency (HP:0004430) | 2.51597084 |
| 54 | Lymphopenia (HP:0001888) | 2.50568502 |
| 55 | Thyroiditis (HP:0100646) | 2.49377871 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.49341055 |
| 57 | Urticaria (HP:0001025) | 2.48636876 |
| 58 | Arterial thrombosis (HP:0004420) | 2.48390096 |
| 59 | Basal ganglia calcification (HP:0002135) | 2.47965676 |
| 60 | Periodontitis (HP:0000704) | 2.46818460 |
| 61 | Eosinophilia (HP:0001880) | 2.45451686 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.41438627 |
| 63 | Hemoptysis (HP:0002105) | 2.40314925 |
| 64 | Combined immunodeficiency (HP:0005387) | 2.39657130 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.35389286 |
| 66 | Recurrent lower respiratory tract infections (HP:0002783) | 2.34032625 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.33925833 |
| 68 | B lymphocytopenia (HP:0010976) | 2.33870381 |
| 69 | Abnormality of B cell number (HP:0010975) | 2.33870381 |
| 70 | Pulmonary embolism (HP:0002204) | 2.32889406 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.32175243 |
| 72 | Increased IgE level (HP:0003212) | 2.30447555 |
| 73 | Granulocytopenia (HP:0001913) | 2.29272987 |
| 74 | IgG deficiency (HP:0004315) | 2.29199621 |
| 75 | Inflammation of the large intestine (HP:0002037) | 2.29066444 |
| 76 | Sepsis (HP:0100806) | 2.25778905 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.25294544 |
| 78 | Abnormality of eosinophils (HP:0001879) | 2.25194020 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.25145209 |
| 80 | Glomerulopathy (HP:0100820) | 2.24382912 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.23555597 |
| 82 | Poor head control (HP:0002421) | 2.23007386 |
| 83 | Gangrene (HP:0100758) | 2.22896268 |
| 84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22056169 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22056169 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22056169 |
| 87 | Skin ulcer (HP:0200042) | 2.20502506 |
| 88 | Hematochezia (HP:0002573) | 2.18411957 |
| 89 | Joint swelling (HP:0001386) | 2.17618061 |
| 90 | Abnormality of the nasal mucosa (HP:0000433) | 2.15981840 |
| 91 | Nasal polyposis (HP:0100582) | 2.15590205 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.14791948 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.14765650 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.13695913 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13695913 |
| 96 | Anorexia (HP:0002039) | 2.13527244 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 2.13097303 |
| 98 | Encephalitis (HP:0002383) | 2.13089367 |
| 99 | Progressive neurologic deterioration (HP:0002344) | 2.11200475 |
| 100 | Episodic fever (HP:0001954) | 2.10857696 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10701641 |
| 102 | Acute hepatic failure (HP:0006554) | 2.10438692 |
| 103 | Vertebral compression fractures (HP:0002953) | 2.10405356 |
| 104 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09739055 |
| 105 | Abnormality of the pleura (HP:0002103) | 2.08630157 |
| 106 | Polyneuropathy (HP:0001271) | 2.07356340 |
| 107 | Increased serum ferritin (HP:0003281) | 2.06989727 |
| 108 | Peritonitis (HP:0002586) | 2.06479638 |
| 109 | Amyloidosis (HP:0011034) | 2.03982230 |
| 110 | Chest pain (HP:0100749) | 2.03967727 |
| 111 | Epistaxis (HP:0000421) | 2.02414136 |
| 112 | Myocardial infarction (HP:0001658) | 2.02382493 |
| 113 | Increased mean platelet volume (HP:0011877) | 2.01326427 |
| 114 | Colitis (HP:0002583) | 2.00546276 |
| 115 | IgA deficiency (HP:0002720) | 2.00310793 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.97382715 |
| 117 | Chronic diarrhea (HP:0002028) | 1.94749142 |
| 118 | Lymphoma (HP:0002665) | 1.93340774 |
| 119 | Disinhibition (HP:0000734) | 1.92647058 |
| 120 | Purpura (HP:0000979) | 1.91913916 |
| 121 | Prolonged bleeding time (HP:0003010) | 1.90951700 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90749670 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90749670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.59541404 |
| 2 | BLK | 3.37098672 |
| 3 | MAP3K14 | 3.11072225 |
| 4 | IRAK4 | 3.02615428 |
| 5 | TBK1 | 2.87692777 |
| 6 | JAK3 | 2.61842073 |
| 7 | TXK | 2.53919220 |
| 8 | TYK2 | 2.52087105 |
| 9 | ZAP70 | 2.48311952 |
| 10 | RIPK4 | 2.35160807 |
| 11 | PIM2 | 2.34983275 |
| 12 | TESK1 | 2.26566442 |
| 13 | GRK7 | 2.23719019 |
| 14 | IKBKE | 2.16940468 |
| 15 | ERN1 | 2.16503416 |
| 16 | KDR | 2.07912216 |
| 17 | NME2 | 2.04962499 |
| 18 | TESK2 | 2.01268511 |
| 19 | KIT | 1.86689130 |
| 20 | MST4 | 1.82978819 |
| 21 | BTK | 1.78636552 |
| 22 | TEC | 1.78315740 |
| 23 | IKBKB | 1.75025420 |
| 24 | IRAK3 | 1.73578924 |
| 25 | SYK | 1.71416464 |
| 26 | STK10 | 1.58969235 |
| 27 | RPS6KA4 | 1.56244700 |
| 28 | ITK | 1.41896984 |
| 29 | CSK | 1.36967032 |
| 30 | LRRK2 | 1.34918953 |
| 31 | SCYL2 | 1.31764329 |
| 32 | MAP3K12 | 1.31076075 |
| 33 | JAK1 | 1.29036610 |
| 34 | PBK | 1.28876371 |
| 35 | LCK | 1.24316730 |
| 36 | CSF1R | 1.21670233 |
| 37 | HCK | 1.18617576 |
| 38 | LIMK1 | 1.17124564 |
| 39 | LYN | 1.15251249 |
| 40 | NEK9 | 1.13704976 |
| 41 | CHUK | 1.12055017 |
| 42 | GRK6 | 1.11530505 |
| 43 | PIM1 | 1.06728267 |
| 44 | PRPF4B | 1.05293242 |
| 45 | MAP3K11 | 1.02568018 |
| 46 | FLT3 | 1.01554511 |
| 47 | MYLK | 1.01310132 |
| 48 | TAOK2 | 1.01270940 |
| 49 | FGFR4 | 0.98069868 |
| 50 | EPHB1 | 0.93838312 |
| 51 | MAP2K3 | 0.92391384 |
| 52 | CLK1 | 0.92296482 |
| 53 | NLK | 0.91737166 |
| 54 | ADRBK2 | 0.91328265 |
| 55 | MOS | 0.88432550 |
| 56 | TAOK1 | 0.87540239 |
| 57 | MARK3 | 0.87279738 |
| 58 | MAP3K13 | 0.86171778 |
| 59 | ERBB3 | 0.85547201 |
| 60 | EIF2AK1 | 0.83877967 |
| 61 | TGFBR2 | 0.83170245 |
| 62 | EIF2AK3 | 0.82508141 |
| 63 | ACVR1B | 0.81837899 |
| 64 | SIK3 | 0.80906950 |
| 65 | TNK2 | 0.80818672 |
| 66 | FGFR3 | 0.79394683 |
| 67 | EPHA3 | 0.78543247 |
| 68 | TRIB3 | 0.77267214 |
| 69 | TRPM7 | 0.77107473 |
| 70 | MAP3K10 | 0.74393868 |
| 71 | MATK | 0.72135453 |
| 72 | PTK2B | 0.68742588 |
| 73 | TGFBR1 | 0.68627558 |
| 74 | STK24 | 0.67598829 |
| 75 | JAK2 | 0.65020598 |
| 76 | FES | 0.63642047 |
| 77 | ABL2 | 0.62914536 |
| 78 | PRKCD | 0.60284698 |
| 79 | MAP3K3 | 0.57958742 |
| 80 | PIK3CG | 0.56982404 |
| 81 | PKN2 | 0.56671174 |
| 82 | TAOK3 | 0.56358158 |
| 83 | STK4 | 0.56196015 |
| 84 | PDK1 | 0.56036620 |
| 85 | MAP3K1 | 0.55828953 |
| 86 | FYN | 0.55390092 |
| 87 | ARAF | 0.54363650 |
| 88 | PRKG2 | 0.53709775 |
| 89 | CAMKK2 | 0.52239328 |
| 90 | CDK19 | 0.50924976 |
| 91 | PAK4 | 0.50356675 |
| 92 | DDR2 | 0.50080570 |
| 93 | CDK6 | 0.45293144 |
| 94 | ABL1 | 0.45230444 |
| 95 | PTK6 | 0.45131299 |
| 96 | PRKCQ | 0.44822267 |
| 97 | * MAPKAPK2 | 0.43324145 |
| 98 | MAP3K6 | 0.43308210 |
| 99 | BMPR2 | 0.43119984 |
| 100 | IRAK1 | 0.42912552 |
| 101 | EIF2AK2 | 0.40865535 |
| 102 | FGR | 0.40277312 |
| 103 | EGFR | 0.40118719 |
| 104 | GRK5 | 0.39895903 |
| 105 | TRIM28 | 0.39850802 |
| 106 | ADRBK1 | 0.39054333 |
| 107 | ILK | 0.38517934 |
| 108 | MAPKAPK3 | 0.38062259 |
| 109 | BRSK2 | 0.37537552 |
| 110 | MAP3K8 | 0.35497638 |
| 111 | INSR | 0.35440111 |
| 112 | FRK | 0.35204948 |
| 113 | BCR | 0.34240788 |
| 114 | RPS6KA6 | 0.34039206 |
| 115 | MAP3K5 | 0.32736609 |
| 116 | PAK1 | 0.32095354 |
| 117 | TLK1 | 0.31429820 |
| 118 | DYRK3 | 0.31388111 |
| 119 | RAF1 | 0.30742761 |
| 120 | PDPK1 | 0.30092692 |
| 121 | DYRK1B | 0.30003222 |
| 122 | YES1 | 0.29113439 |
| 123 | PASK | 0.28890170 |
| 124 | MAP4K2 | 0.28301704 |
| 125 | IGF1R | 0.27502729 |
| 126 | RPS6KA5 | 0.26813424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.01101790 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.50842361 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.38503620 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.28294880 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26375533 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.14383451 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.13223525 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.12579107 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10237165 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02445776 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02006668 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00844415 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98413494 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.93137857 |
| 15 | * Shigellosis_Homo sapiens_hsa05131 | 1.92656435 |
| 16 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.87439462 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84163255 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.82055781 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80670428 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.78603994 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.76039979 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.73872144 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70743435 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.66770472 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.53382892 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51507459 |
| 27 | * Salmonella infection_Homo sapiens_hsa05132 | 1.51138646 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.50819135 |
| 29 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47607822 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.46765386 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.44781517 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44518228 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43308522 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.41492068 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40474090 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40339867 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.40009997 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38441462 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37995297 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37928393 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37394845 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34644981 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30194189 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27038890 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26751767 |
| 46 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25010293 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.23001132 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19139198 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.16389975 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15856517 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10729517 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10122871 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97204760 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96868367 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96557578 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93661856 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91562466 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.88798313 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.87217501 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87077266 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86811588 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86310377 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 0.85615040 |
| 64 | Ribosome_Homo sapiens_hsa03010 | 0.85486865 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82373677 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81741136 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80608054 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79303825 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74156586 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72634279 |
| 71 | Base excision repair_Homo sapiens_hsa03410 | 0.70989381 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69995288 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67195144 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65475129 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64424941 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63747707 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63509457 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60934263 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60526694 |
| 80 | * Endocytosis_Homo sapiens_hsa04144 | 0.55081196 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53811422 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.53116023 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52573606 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52452158 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48310182 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46137118 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44609812 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44156510 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43785636 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43348675 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42597010 |
| 92 | Mismatch repair_Homo sapiens_hsa03430 | 0.42502555 |
| 93 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40788067 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38720356 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38235069 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34769605 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31301033 |
| 98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30125674 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29277568 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29084745 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28878167 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28556594 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.28466859 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28321246 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27886361 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27589393 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27115862 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25867507 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.24416502 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19784177 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16363295 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.14783006 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12765238 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.11722016 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.10318203 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07831550 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05184125 |

